Squarepoint
EVH icon

Squarepoint’s Evolent Health EVH Stock Holding History

Squarepoint’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,700
Closed -$143K – 4818
2024
Q4 		$143K Sell
12,700
-12,300
-49% -$216K ﹤0.01% 4588
2024
Q3 		$707K Buy
+25,000
New +$644K ﹤0.01% 2861

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's EVH Position: Q1 2026 in Review

Squarepoint reduced its Evolent Health (EVH) stake by 59% in Q1 2026, selling an estimated $1.78M and leaving 390,294 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #2874.

Squarepoint first reported a position in EVH in Q4 2016 and has held it in 20 quarters since. The position peaked at $3.81M in Q4 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Squarepoint held 390,294 shares of Evolent Health worth $890K as of Q1 2026.
  • Squarepoint sold 561,885 Evolent Health shares in Q1 2026, an estimated $1.78M.
  • Evolent Health made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2874 holding.
  • Squarepoint first reported a position in Evolent Health in Q4 2016 and has held it in 20 quarters since.
  • Squarepoint's Evolent Health position peaked at $3.81M in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.